ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 464

$610K Total Retail Price of All Prescriptions

Rank: 3 out of 464

391 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 10,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,048 950 1 8
SIMVASTATIN 450 379 2 3
LISINOPRIL 431 408 3 1
FUROSEMIDE 367 337 4 5
TRAZODONE HCL 360 297 5 45
AMLODIPINE BESYLATE 352 333 6 6
METOPROLOL TARTRATE 340 320 7 4
LEVOTHYROXINE SODIUM 316 271 8 19
MIRTAZAPINE 273 260 9 65
OMEPRAZOLE 250 230 10 18
CITALOPRAM HBR 241 220 11 31
GABAPENTIN 200 147 12 41
DONEPEZIL HCL 199 194 13 66
METFORMIN HCL 186 155 14 22
RISPERIDONE 179 158 15 97
OLANZAPINE 176 163 16 112
QUETIAPINE FUMARATE 155 125 17 99
NAMENDA 146 146 18 88
TRAMADOL HCL 142 140 19 55
POTASSIUM CHLORIDE 142 114 19 40
DIVALPROEX SODIUM 138 111 21 104
SERTRALINE HCL 133 132 22 50
ATORVASTATIN CALCIUM 132 112 23 7
CARBIDOPA-LEVODOPA 130 128 24 129
METOPROLOL SUCCINATE 128 117 25 2
CYMBALTA 98 89 26 119
ATENOLOL 95 78 27 9
HYDROCHLOROTHIAZIDE 95 92 27 10
LEVETIRACETAM 83 54 29 143
LIDODERM 81 81 30 117
TAMSULOSIN HCL 79 75 31 47
POLYETHYLENE GLYCOL 3350 75 67 32 124
BUPROPION HCL SR 72 72 33 144
DIGOXIN 70 69 34 14
GLIPIZIDE 68 67 35 78
ABILIFY 68 55 35 146
LACTULOSE 66 51 37 152
SEROQUEL 65 41 38 154
DOXAZOSIN MESYLATE 63 60 39 42
SPIRIVA 63 62 39 81
RANITIDINE HCL 58 52 41 48
LAMOTRIGINE 58 54 41 159
LANTUS 57 36 43 111
IBUPROFEN 57 40 43 93
CLOZAPINE 55 25 45 166
ALLOPURINOL 54 45 46 35
ADVAIR DISKUS 52 52 47 76
FINASTERIDE 51 51 48 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.